BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21044127)

  • 1. Cytokine levels in serious cardiopathy of Chagas disease after in vitro stimulation with recombinant antigens from Trypanosoma cruzi.
    Lorena VM; Lorena IM; Braz SC; Melo AS; Melo MF; Melo MG; Silva ED; Ferreira AG; Morais CN; Costa VM; Correa-Oliveira R; Gomes YM
    Scand J Immunol; 2010 Dec; 72(6):529-39. PubMed ID: 21044127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10 and IFN-γ gene expression in chronic Chagas disease patients after in vitro stimulation with recombinant antigens of Trypanosoma cruzi.
    de Melo AS; de Lorena VM; de Moura Braz SC; Docena C; de Miranda Gomes Y
    Cytokine; 2012 May; 58(2):207-12. PubMed ID: 22325340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.
    Vitelli-Avelar DM; Sathler-Avelar R; Teixeira-Carvalho A; Pinto Dias JC; Gontijo ED; Faria AM; Elói-Santos SM; Martins-Filho OA
    Scand J Immunol; 2008 Nov; 68(5):516-25. PubMed ID: 18803607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of IgA antibodies against CRA and FRA recombinant antigens of Trypanosoma cruzi differentiate digestive forms of Chagas disease.
    Vasconcelos RH; Amaral FN; Cavalcanti MG; Silva ED; Ferreira AG; Morais CN; Gomes YM
    Hum Immunol; 2010 Oct; 71(10):964-7. PubMed ID: 20659514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.
    Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO
    Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin M antibodies against CRA and FRA recombinant antigens of Trypanosoma cruzi in chronic chagasic patients.
    Vasconcelos RH; Azevedo EA; Cavalcanti MG; Silva ED; Ferreira AG; Morais CN; Gomes YM
    Hum Immunol; 2011 May; 72(5):402-5. PubMed ID: 21371515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troponin T autoantibodies correlate with chronic cardiomyopathy in human Chagas disease.
    Nunes DF; Guedes PM; Andrade Cde M; Câmara AC; Chiari E; Galvão LM
    Trop Med Int Health; 2013 Oct; 18(10):1180-92. PubMed ID: 23906320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease.
    Gomes JA; Molica AM; Keesen TS; Morato MJ; de Araujo FF; Fares RC; Fiuza JA; Chaves AT; Pinheiro V; Nunes Mdo C; Correa-Oliveira R; da Costa Rocha MO
    Hum Immunol; 2014 Jan; 75(1):20-8. PubMed ID: 24071371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune response from Chagasic patients to CRA or FRA recombinant antigens of Trypanosoma cruzi.
    Lorena VM; Verçosa AF; Machado RC; Moitinho-Silva L; Cavalcanti MG; Silva ED; Ferreira AG; Correa-Oliveira R; Pereira VR; Gomes YM
    J Clin Lab Anal; 2008; 22(2):91-8. PubMed ID: 18348314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired phagocytic capacity driven by downregulation of major phagocytosis-related cell surface molecules elicits an overall modulatory cytokine profile in neutrophils and monocytes from the indeterminate clinical form of Chagas disease.
    Gomes JA; Campi-Azevedo AC; Teixeira-Carvalho A; Silveira-Lemos D; Vitelli-Avelar D; Sathler-Avelar R; Peruhype-Magalhães V; Silvestre KF; Batista MA; Schachnik NC; Correa-Oliveira R; Eloi-Santos S; Martins-Filho OA
    Immunobiology; 2012 Oct; 217(10):1005-16. PubMed ID: 22387073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients.
    Gomes JA; Bahia-Oliveira LM; Rocha MO; Busek SC; Teixeira MM; Silva JS; Correa-Oliveira R
    Infect Immun; 2005 Dec; 73(12):7960-6. PubMed ID: 16299288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.
    Sathler-Avelar R; Vitelli-Avelar DM; Massara RL; Borges JD; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
    Scand J Immunol; 2006 Nov; 64(5):554-63. PubMed ID: 17032249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific activation of CD4
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Nunes MDCP; Gollob KJ; Dutra WO
    Clin Exp Immunol; 2017 Oct; 190(1):122-132. PubMed ID: 28543170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease.
    Medeiros NI; Fares RC; Franco EP; Sousa GR; Mattos RT; Chaves AT; Nunes MD; Dutra WO; Correa-Oliveira R; Rocha MO; Gomes JA
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005284. PubMed ID: 28118356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in the expression of CD4 + CD25+ lymphocytic T cells in the indeterminate clinical form of human Chagas disease after stimulation with recombinant antigens of Trypanosoma cruzi.
    de Moura Braz SC; de Melo AS; da Glória Aureliano de Melo Cavalcanti M; Martins SM; de Oliveira W; da Silva ED; Ferreira AG; de Lorena VM; de Miranda Gomes Y
    J Clin Immunol; 2014 Nov; 34(8):991-8. PubMed ID: 25205548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection.
    Abel LC; Rizzo LV; Ianni B; Albuquerque F; Bacal F; Carrara D; Bocchi EA; Teixeira HC; Mady C; Kalil J; Cunha-Neto E
    J Autoimmun; 2001 Aug; 17(1):99-107. PubMed ID: 11488642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
    Laucella SA; Rottenberg ME; de Titto EH
    Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation and bystander suppression induced by membrane and flagellar antigens of Trypanosoma cruzi.
    Mosca W; Briceño L
    Invest Clin; 2009 Mar; 50(1):77-87. PubMed ID: 19418729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Human CD11b
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Alves MLR; Giunchetti RC; Nunes MDCP; Gollob KJ; Dutra WO
    Front Immunol; 2018; 9():3015. PubMed ID: 30662439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production.
    Van Voorhis WC
    J Immunol; 1992 Jan; 148(1):239-48. PubMed ID: 1727869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.